Topic: Reuters Group plc

Vertex hep C drug achieves 75 pct cure rate: study

NEW YORK (Reuters) - A closely watched experimental hepatitis C treatment being developed by Vertex Pharmaceuticals Inc led to a 75 percent cure rate in a pivotal late-stage trial of previously untreated patients, the company said on Tuesday. The results from the ...

Sex hormone explains higher liver cancer risk in men

HONG KONG (Reuters) - Male sex hormones may explain why men who suffer from the hepatitis B liver disease are more likely to develop liver cancer than women, researchers in Taiwan have found. In a paper published in Science Translational Medicine on ...

Bollywood star Bachchan says has cirrhosis

MUMBAI (Reuters) - Amitabh Bachchan, one of India's top actors, whose disciplined, teetotaling life is somewhat rare in Bollywood, has said his liver has been partially destroyed by cirrhosis, requiring constant medical attention. The 67-year-old Bollywood star said the condition was caused ...

Jailed China activist Hu Jia may have cancer-wife

BEIJING (Reuters) - Imprisoned Chinese AIDS activist Hu Jia is suffering from a serious disease, possibly liver cancer, his wife said on Thursday after making a formal appeal to security forces to release him on medical parole. Hu's mother saw a suspected ...

Team finds potential path for hepatitis C drugs

WASHINGTON (Reuters) - U.S. scientists have identified a new class of drugs that appear to block the hepatitis C virus from replicating in laboratory experiments, researchers said on Wednesday. The team discovered activity within a key protein of the hepatitis C virus ...

Coffee may slow liver damage from hepatitis

NEW YORK (Reuters Health) - A few cups of coffee everyday may help slow the progression of liver disease associated with long-term infection with the hepatitis C virus, a new study hints. Researchers found that among 766 patients with hepatitis C-related liver ...

Both hepatitis C drugs work about the same: study

CHICAGO (Reuters) - Two standard treatments for hepatitis C work equally well at knocking down the virus for most patients, U.S. researchers reported on Wednesday. The findings, from a 3,000-patient comparative effectiveness study, are meant to help guide doctors' decisions about which ...

Belly fat tied to liver cancer recurrence

NEW YORK (Reuters Health) - The amount of fat accumulated around internal abdominal organs appears to affect the likelihood of a recurrence of liver cancer following treatment, Japanese researchers report. Dr. H. Yoshida of the University of Tokyo and colleagues came to ...

Valuev v Chagaev WBA heavyweight title fight cancelled

HELSINKI (Reuters) - The WBA heavyweight title fight between Nikolai Valuev of Russia and Ruslan Chagaev of Uzbekistan scheduled for Saturday has been canceled, a spokesman for the promoters said on Friday. "The title match between Valuev and Chagaev had been canceled ...

Pollution may contribute to rise in liver disease

CHICAGO (Reuters) - Pollutants may be contributing to a sharp increase in the number of cases of liver disease, U.S. researchers said on Friday. They said as many as a third of U.S. adults showed signs of having liver disease not caused ...
Previous
  • 1
  • 2